<unk>  is indicated for the treatment and prophylaxis of bleeding in people with haemophilia A (congenital factor-VIII deficiency). It is appropriate for use in adults and children of all ages, including newborns. It does not contain von-Willebrand factor, and hence is not indicated in von-Willebrand's disease.
Moroctocog alfa
Susoctocog alfa
Efmoroctocog alfa
Proglucagon
Vonicog alfa
Difelikefalin
Transfluthrin
Damoctocog alfa pegol